Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action

Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action

Background:. In response to the devastating effects of the coronavirus disease 2019 pandemic, several vaccine prototypes have been developed, with the Pfizer/BioNTech (BNT162b2) platform being the first to receive emergency use authorization. Although taken to market on an unprecedented timeline, th...

Full description

Bibliographic Details
Main Authors: Ashleigh Frank, DO, Sara Radparvar, PharmD, BCPS, BCCCP, Anthony Manasia, MD, FCCP, Adel Bassily-Marcus, MD, Roopa Kohli-Seth, MD
Format: Article
Language:English
Published: Wolters Kluwer 2021-04-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000397

Similar Items

Similar Items